Effect of Two Iron Preparations on Protein in the Urine
Phase 4
Completed
- Conditions
- Kidney Failure, ChronicAnemia, Iron-Deficiency
- Interventions
- Drug: Sodium Ferric Gluconate and Iron sucrose
- Registration Number
- NCT00354692
- Lead Sponsor
- Watson Pharmaceuticals
- Brief Summary
This pilot study will compare the effects of sodium ferric gluconate complex and iron sucrose on urine concentrations of various chemicals including protein
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
- Moderate to severe anemia
- Iron deficiency
- Moderate to severe chronic kidney disease
- Age ≥ 18 or greater and able to give informed consent
Exclusion Criteria
- Receiving dialysis
- Known sensitivity to Sodium Ferric Gluconate Complex in Sucrose Injection, Iron sucrose USP, or any of their components
- Clinically unstable
- Indication of iron sufficiency
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Experimental Sodium Ferric Gluconate and Iron sucrose -
- Primary Outcome Measures
Name Time Method Change in urine protein 180 minutes
- Secondary Outcome Measures
Name Time Method Change in various urine chemicals 180 minutes